MedPath

Effects of Lactobacillus Rhamnosus and Inulin supplements (singly & both) on phenolic uremic toxins, nutritional status and Functional GI Disorders (FGIDs) in hemodialysis patients

Not Applicable
Conditions
End stage kidney disease on dialysis.
Chronic kidney disease, stage 5
Registration Number
IRCT201504182017N21
Lead Sponsor
Vice chancellor for research, Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
96
Inclusion Criteria

Physician definitive diagnosis of end stage of renal disease (ESRD) treated by hemodialysis; both male and female; aged 20 years and older; acceptable performance of the digestive system; ability to drink at least 100 ml of water per day; life expectancy and survival at least 3 months; absence of acute medical conditions; accept and sign the project. Exclusion criteria: Patient reluctance to participate in the study; treated with peritoneal dialysis or kidney transplantation; intolerance supplements; pregnant women; lactating women; smoking; acute medical illness; use of antibiotics; use of psychedelic drugs; use of herbal medicines and flavors.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath